Natural language search

Discover Funding Opportunities

Search by topic, keyword, or describe what you need in plain language.

Sign in to match opportunities to your profile.

Type
Closing date
Amount
4 funding opportunities
External

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. All applications must be within the scope of the mission of one of the participating NIH Institutes/Centers. This R21 grant mechanism supports exploratory/developmental research and is designed for projects where preliminary data may be limited.

+6
Jan 07, 2028
External

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

National Institutes of Health

This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways to control cancer. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (epidemiologic, biomedical, behavioral, health care delivery or clinical).

+6
Sep 07, 2028
External

Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)

National Institutes of Health

Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood. The purpose of this initiative is to advance translational research to better understand the emergence and trajectory of schizophrenia and related disorders in mid to late life, and to identity targets for future development of prevention and treatment efforts. This R21 grant mechanism supports exploratory and developmental research projects in this critical area of mental health.

+8
Sep 07, 2026
External

Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language development in children and that focuses on the development of novel measures of children's language development. The overall goal is to build the number of strengths-focused, culturally and linguistically responsive, and generalizable tools to further our understanding of children's language development and/or impairment, and predictors thereof. This R21 grant mechanism supports exploratory and developmental research projects that have the potential to contribute to significant scientific advances.

+6
Sep 07, 2027